| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/01/2002 | US20020103249 Combination of a serotonin reuptake inhibitor and irindalone |
| 08/01/2002 | US20020103247 Indole and dihydroindole derivatives |
| 08/01/2002 | US20020103245 1-aryl or heteroaryl substituted 5-amino-4 carbonylpyrazole derivatives; antiinflammatory agents |
| 08/01/2002 | US20020103244 Antifatigue composition |
| 08/01/2002 | US20020103242 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 08/01/2002 | US20020103241 Such as N-benzooxazol-2-yl-3-cyclopentyl-2-(4-methanesulfonyl -phenyl)-propionamide for increasing insulin secretion in the treatment of type II diabetes |
| 08/01/2002 | US20020103235 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
| 08/01/2002 | US20020103231 Such as 4-chloro-N-(4-(6-chloro-3a-hydroxy-8,8a-dihydro-3aH-indeno(1,2-d)thiazol-2 -yl)-phenyl)benzene-sulfonamide; for the prophylaxis or treatment of obesity |
| 08/01/2002 | US20020103229 Indazole derivatives as JNK inhibitors and compositions and methods related thereto |
| 08/01/2002 | US20020103227 Nitric oxide synthase inhibitors such as 6(4'-(4-phenethyl-piperazin-1-ylmethyl)-biphenyl-4-yl)-pyridin-2-ylamine for treatment and prevention of central nervous system disorders |
| 08/01/2002 | US20020103225 Comprises solid amorphous dispersion of compounds such as (2R,4S)4-((3,5-dichloro-benzyl)-methoxycarbonyl-amino)-6,7-dimethoxy-2 -methyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester for elevating plasma lipid levels |
| 08/01/2002 | US20020103221 Such as 2-amino-N-(2-(3a-(R)-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7-hexahydro-pyrazolo -(4,3-c)pyridin-5-yl)-1-(R)-benzyloxymethyl- 2-oxo-ethyl)-isobutyramide or prodrug thereof; for improving functional health of elderly/isolated |
| 08/01/2002 | US20020103213 Pyrimidone compounds which are inhibitors of the enzyme Lp-PLA2; use in treating atheroscelerosis |
| 08/01/2002 | US20020103211 For treatment of chronic inflammatory disease, chronic intestinalinflammation, arthritis, psoriasis, asthma, autoimmune disorders |
| 08/01/2002 | US20020103209 Serotonergic modulators; for treatment of disorders of the central nervous system including psychotic disorders, hypertension and vascular disorders, migraine |
| 08/01/2002 | US20020103201 Selective NPY (Y5) antagonists (triazines) |
| 08/01/2002 | US20020103199 Fused heteroaromatic glucokinase activators |
| 08/01/2002 | US20020103193 2-(2-(4-hexyl-3,4-dihydro-3-oxo-2H-1,4-benzoxazin-2-yl)ethoxy) - benzeneacetic acid for example; prophylaxis of onset of glucose or lipid metabolism disorders, such as non-insulin dependant diabetes mellitus or obesity |
| 08/01/2002 | US20020103183 Insulin receptor kinase activators; treating hyperglycemia; 4-((3,5-bis(N-(4-sulfophenyl)carbamoyl)phenyl)carbonylamino)-benzenesulfonic acid, for example |
| 08/01/2002 | US20020103182 Improving elasticity or reducing wrinkles of a skin, for example; advanced glycosylation endproducts" or AGEs |
| 08/01/2002 | US20020103173 Vitamin D3 derivative and treating agent for inflammatory respiratory disease using same |
| 08/01/2002 | US20020103172 Vitamin d3 derivatives |
| 08/01/2002 | US20020103167 Method of treating certain eye diseases |
| 08/01/2002 | US20020103150 Screening for compounds that affect uncoupling by contacting a cell or tissue sample with a candidate compound and analyzing the expression of human OGC; treating metabolic disorders, e.g. cachexcia; gene therapy |
| 08/01/2002 | US20020103131 Prevention of diabetes by administration of GnRH antagonists |
| 08/01/2002 | US20020103123 Administering coumpounds such as aromatic alkyl diamine derivatives as Y5 receptor agonist or antagonist to increase or decrease food consumption |
| 08/01/2002 | US20020103111 Comprising peptide sequences which mimic the conserved amino acid motif LDTSL of MAdCAM-1 and which have groups bonded to the N- and C- termini; treatment of inflammatory bowel disease |
| 08/01/2002 | US20020102712 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of viral diseases |
| 08/01/2002 | US20020102707 Nucleotide sequences coding polypeptide for use in the treatment of sexual disorders |
| 08/01/2002 | US20020102649 Human transport protein homologs |
| 08/01/2002 | US20020102619 Heparanase specific molecular probes and their use in research and medical applications |
| 08/01/2002 | US20020102609 Antagonists of HMG1 for treating inflammatory conditions |
| 08/01/2002 | US20020102552 Nucleotide sequences coding preferential polypeptide for use in the treatment of diabetes and eating disorders |
| 08/01/2002 | US20020102535 Nucleic acid molecules and polypeptides for immune modulation |
| 08/01/2002 | US20020102315 For therapy of diabetes to be administered perorally in form of tea, a tincture and a pill |
| 08/01/2002 | US20020100854 Furnace mount and method of installation |
| 08/01/2002 | DE10104494A1 Verfahren zur Herstellung von Trockenpulvern eines oder mehrerer Carotinoide A process for preparing dry powders of one or more carotenoids |
| 08/01/2002 | CA2735478A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/01/2002 | CA2735267A1 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 08/01/2002 | CA2563051A1 Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 08/01/2002 | CA2436139A1 Methods of inducing organ transplant tolerance and correcting hemoglobinopathies |
| 08/01/2002 | CA2435829A1 Trisubstituted carbocyclic cyclophilin binding compounds and their use |
| 08/01/2002 | CA2435826A1 Differentiation of stem cells to pancreatic endocrine cells |
| 08/01/2002 | CA2435647A1 Urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and use |
| 08/01/2002 | CA2435566A1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 08/01/2002 | CA2435047A1 Constitutively desensitized g protein-coupled receptors |
| 08/01/2002 | CA2434929A1 Method of treatment of type i diabetes |
| 08/01/2002 | CA2434558A1 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 08/01/2002 | CA2434504A1 Combinations of sterol absorption inhibitor(s) with blood modifiers for treating vascular conditions |
| 08/01/2002 | CA2434488A1 Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications |
| 08/01/2002 | CA2434436A1 Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions |
| 08/01/2002 | CA2434430A1 The use of substituted azetidinone compounds for the treatment of sitosterolemia |
| 08/01/2002 | CA2434033A1 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 08/01/2002 | CA2433025A1 Substituted piperidines/piperazines as melanocortin receptor agonists |
| 08/01/2002 | CA2432988A1 Melanocortin receptor agonists |
| 08/01/2002 | CA2432985A1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists |
| 08/01/2002 | CA2432134A1 Adenylate cyclases |
| 08/01/2002 | CA2432122A1 Aryl and aminoaryl substituted serotonin receptor agonist and antagonist ligands |
| 08/01/2002 | CA2431996A1 Melanocortin receptor agonists |
| 08/01/2002 | CA2431970A1 Substituted pyrazinoquinoxaline derivatives as serotonin receptor agonists and antagonists |
| 08/01/2002 | CA2431517A1 Polynucleotides encoding cellular transporters and methods of use thereof |
| 08/01/2002 | CA2426102A1 Method of diagnosing and treating cartilaginous disorders |
| 07/31/2002 | EP1227151A1 Glucagon-like insulinotropic peptide analogs, compositions, and methods of use |
| 07/31/2002 | EP1227105A1 Ghsr ligand polypeptides and dnas thereof |
| 07/31/2002 | EP1227092A2 Isonitrile intermediates for the preparation of tri-substituted imidazole compounds with multiple therapeutic properties |
| 07/31/2002 | EP1227091A2 Formamide intermediates for the preparation of tri-substituted imidazole compounds with multiple therapeutic properties |
| 07/31/2002 | EP1227090A1 Amine derivatives |
| 07/31/2002 | EP1227083A1 3-AMINOPIPERIDINE DERIVATIVES AS INTEGRIN $g(a)v$g(b)3 ANTAGONISTS |
| 07/31/2002 | EP1227081A1 Process for the preparation of oxyiminoalkanoic acid derivatives |
| 07/31/2002 | EP1226435A1 Axor35, a g-protein coupled receptor |
| 07/31/2002 | EP1226247A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 07/31/2002 | EP1226246A1 Polypeptides with expanded primary signalling motifs |
| 07/31/2002 | EP1226245A2 Hybrid adaptor receptors |
| 07/31/2002 | EP1226244A2 Polypeptides with non-natural primary signalling motifs |
| 07/31/2002 | EP1226242A1 Human cub-domain-containing protein and gene encoding the same |
| 07/31/2002 | EP1226239A1 Methods of producing differentiated progenitor cells and lineage-defective embryonic stem cells |
| 07/31/2002 | EP1226231A1 19 human secreted proteins |
| 07/31/2002 | EP1226178A1 Recombinant fusion molecules |
| 07/31/2002 | EP1226160A2 Novel antiarrhythmic peptides |
| 07/31/2002 | EP1226159A1 Substituted dipeptides having nos inhibiting activity |
| 07/31/2002 | EP1226143A2 Imidazopyridine derivatives used as phosphodiesterase vii inhibitors |
| 07/31/2002 | EP1226141A1 Heterocyclic substituted pyrazolones |
| 07/31/2002 | EP1226137A1 Phenyl- and pyridyl-tetrahydro-pyridines having tnf inhibiting activity |
| 07/31/2002 | EP1226126A1 Pyrimidine derivatives |
| 07/31/2002 | EP1226124A1 Heterocyclically substituted benzoylguanidine, method for the production thereof, the use thereof as a medicament or means of diagnosis and a medicament containing the same |
| 07/31/2002 | EP1226115A1 Novel carbamates and ureas |
| 07/31/2002 | EP1226110A1 Bicyclic amino acids as pharmaceutical agents |
| 07/31/2002 | EP1226109A2 Phenyl amine carboxylic acid compounds and compositions for delivering active agents |
| 07/31/2002 | EP1226104A1 Phenoxy carboxylic acid compounds and compositions for delivering active agents |
| 07/31/2002 | EP1225922A1 Selective toxin expression in angiogenic endothelial cells |
| 07/31/2002 | EP1225912A1 A method of prophylaxis and treatment |
| 07/31/2002 | EP1225910A2 MODULATION OF eNOS ACTIVITY AND THERAPEUTIC USES THEREOF |
| 07/31/2002 | EP1225903A2 Aminoalkylenephosphonates for treatment of bone disorders |
| 07/31/2002 | EP1225901A2 Uses and compositions for treating platelet-related disorders using anagrelide |
| 07/31/2002 | EP1225900A1 Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 07/31/2002 | EP1225814A1 Fibrous-liponutritional complexes and compositions containing them |
| 07/31/2002 | EP1225813A1 Cholesterol reducing stanol compositions, preparation and method of use |
| 07/31/2002 | EP1225812A2 Cholesterol reducing sterol compositions, preparation and method of use |
| 07/31/2002 | EP1225809A2 Methods for stabilizing liquid nutritional products and products so stabilized |
| 07/31/2002 | EP0744955B1 Cyclic heptapeptide anti-inflammatory agent |